Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Garfield

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Seminars in Radiation Oncology|March 28, 2002
Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiationMatthew Arquette, Todd Wasserman, Ramaswamy Govindan, et al.
Thoracic Cancer|September 19, 2017
Prognostic factors for survival in a Chinese population presenting with advanced non-small cell lung cancer with an emphasis on smoking status: A regional, single-institution, retrospective analysis of 4552 patientsQiong Hu, Bing Li, David Garfield, et al.
Brain Injury|September 25, 2015
Traumatic brain injury, coronary atherosclerosis and cardiovascular mortalityNaser Ahmadi, Fereshteh Hajsadeghi, Rachel Yehuda, et al.
Respiration; International Review of Thoracic Diseases|January 25, 2012
Cough and hemoptysis in a middle-aged womanHaiyan Ge, David Garfield, Suqin Ben, et al.
Clinical Lung Cancer|December 6, 2011
A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced inoperable non-small-cell lung cancerDennis L Carter, David Garfield, James Hathorn, et al.
The Journal of International Medical Research|May 15, 2013
CYP19A1 gene polymorphisms and risk of lung cancerJie Zhang, Yue Yin, Xiao-Min Niu, et al.
Acta Pharmacologica Sinica|March 27, 2012
FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cellsNuo Xu, Xin Zhang, Xun Wang, et al.
Oncotargets and Therapy|December 19, 2013
Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trialsYiliang Zhang, Yihua Sun, Lei Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 28, 2003
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancerMark A Socinski, Marcus A Neubauer, Jairo Olivares, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2021
An otopetrin family proton channel promotes cellular acid efflux critical for biomineralization in a marine calcifierWilliam W Chang, Ann-Sophie Matt, Marcus Schewe, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Seminars in Radiation Oncology|March 28, 2002
Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiationMatthew Arquette, Todd Wasserman, Ramaswamy Govindan, et al.
Thoracic Cancer|September 19, 2017
Prognostic factors for survival in a Chinese population presenting with advanced non-small cell lung cancer with an emphasis on smoking status: A regional, single-institution, retrospective analysis of 4552 patientsQiong Hu, Bing Li, David Garfield, et al.
Brain Injury|September 25, 2015
Traumatic brain injury, coronary atherosclerosis and cardiovascular mortalityNaser Ahmadi, Fereshteh Hajsadeghi, Rachel Yehuda, et al.
Respiration; International Review of Thoracic Diseases|January 25, 2012
Cough and hemoptysis in a middle-aged womanHaiyan Ge, David Garfield, Suqin Ben, et al.
Clinical Lung Cancer|December 6, 2011
A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced inoperable non-small-cell lung cancerDennis L Carter, David Garfield, James Hathorn, et al.
The Journal of International Medical Research|May 15, 2013
CYP19A1 gene polymorphisms and risk of lung cancerJie Zhang, Yue Yin, Xiao-Min Niu, et al.
Acta Pharmacologica Sinica|March 27, 2012
FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cellsNuo Xu, Xin Zhang, Xun Wang, et al.
Oncotargets and Therapy|December 19, 2013
Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trialsYiliang Zhang, Yihua Sun, Lei Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 28, 2003
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancerMark A Socinski, Marcus A Neubauer, Jairo Olivares, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2021
An otopetrin family proton channel promotes cellular acid efflux critical for biomineralization in a marine calcifierWilliam W Chang, Ann-Sophie Matt, Marcus Schewe, et al.
Pageof 5